| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 6.69▼ | 6.83▼ | 6.83▼ | 6.37▲ | 6.38▲ |
| MA10 | 6.92▼ | 6.81▼ | 6.77▼ | 6.22▲ | 8.22▼ |
| MA20 | 6.80▼ | 6.84▼ | 6.52▲ | 6.39▲ | 7.01▼ |
| MA50 | 6.63▼ | 6.53▼ | 6.50▲ | 8.02▼ | 21.07▼ |
| MA100 | 6.80▼ | 7.51▼ | 8.20▼ | 6.92▼ | 107.02▼ |
| MA200 | 7.60▼ | 9.16▼ | 7.84▼ | 18.48▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.062▼ | -0.020▼ | 0.019▲ | 0.124▲ | 1.420▲ |
| RSI | 41.295▼ | 47.488▼ | 48.570▼ | 47.559▼ | 36.091▼ |
| STOCH | 28.842 | 59.635 | 36.105 | 23.495 | 20.600 |
| WILL %R | -91.279▼ | -68.261 | -82.346▼ | -79.181▼ | -74.505 |
| CCI | -93.898 | -50.513 | -45.925 | 30.809 | -4.942 |
|
Wednesday, July 15, 2026 06:43 AM
Ernexa Therapeutics (NASDAQ:ERNA) shares surged 30% on Wednesday after the company announced positive independent preclinical data supporting its lead cell therapy candidate, ERNA-101, for the ...
|
|
Wednesday, July 15, 2026 03:42 AM
NTHI to provide ongoing news coverage of expected upcoming catalysts and events as well as market outreach services. This should not be construed as financial or investment advice. Trading involves ...
|
|
Wednesday, July 15, 2026 12:50 AM
Independent CRO Successfully Reproduces ERNA-101 Combination Data in Larger Preclinical Study, Significantly Strengthening Confidence as Company ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/07/26 | 6.95 | 7.21 | 6.42 | 6.42 | 117,828 |
| 16/07/26 | 7.55 | 7.59 | 6.731 | 7.12 | 457,931 |
| 15/07/26 | 8.51 | 9.90 | 6.11 | 6.73 | 26,100,458 |
| 14/07/26 | 5.89 | 6.15 | 5.7719 | 6.06 | 18,781 |
| 13/07/26 | 5.86 | 6.00 | 5.505 | 5.54 | 20,564 |
| 10/07/26 | 6.13 | 6.20 | 5.78 | 6.06 | 14,307 |
| 09/07/26 | 6.24 | 6.36 | 5.71 | 5.93 | 35,397 |
| 08/07/26 | 6.425 | 6.425 | 5.73 | 5.73 | 20,351 |
| 07/07/26 | 6.55 | 6.67 | 6.20 | 6.20 | 7,066 |
| 06/07/26 | 6.39 | 6.725 | 6.39 | 6.44 | 18,376 |
|
|
||||
|
|
||||
|
|